Bharat (BIBCL) | Stock Overview & Key Data
Bharat Performance Comparison
Stock Range
Today's Range
Low: ₹20.82
High: ₹21.30
on October 7, 2025
52 Week Range
Low: ₹19.00
High: ₹35.88
on February 17, 2025
on January 7, 2025
All-Time High: ₹94.50 on June 14, 2021
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR910.7M
EPS
-4.18
P/E Ratio (TTM)
-5.48
Forward P/E
N/A
P/B Ratio
1.16
PEG Ratio
-0.09
Div. Yield
N/A
ROE
-21.00%
Beta
0.905
Debt to Equity
94.48
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-2,888.44%
Profit Margin
-241.59%
Returns and Earnings
Return on Assets (TTM)
-6.28%
Return on Equity (TTM)
-21.00%
EBITDA
INR-198.7M
Net Income (TTM)
INR-184.8M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR1.77
Quarterly Revenue Growth (YoY)
-99.40%
Quarterly Earnings Growth (YoY)
-100.00%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Bharat BIBCL | 910.67M Small-cap | -1.73% | -4.53% | -11.28% | -1.73% | -13.82% | -21.99% | -13.47% | -4.44% |
| Biocon BIOCON | 470.24B Large-cap | 2.23% | -4.50% | -6.54% | 13.09% | -5.71% | 0.46% | 33.08% | -22.36% |
| OneSource Specialty ONESOURCE | 214.44B Large-cap | 4.10% | 2.01% | -6.31% | 36.01% | 9.48% | 9.48% | 9.48% | 9.48% |
| Zota Health Care ZOTA | 46.71B Small-cap | 9.96% | 2.50% | 19.40% | 101.76% | 93.20% | 149.64% | 455.76% | 968.70% |
| Dishman Carbogen DCAL | 45.33B Small-cap | 6.48% | 2.11% | 8.18% | 50.32% | 0.86% | 57.44% | 186.03% | 83.63% |
| Panacea Biotec PANACEABIO | 26.29B Small-cap | 5.39% | 5.59% | 5.47% | -3.12% | -2.63% | 38.79% | 196.98% | 135.53% |
Ownership & Short Interest
Insider Ownership
59.25%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
16K
Average 90-Day Volume
26K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is BIBCL's 52-week high and low?
- In the last 52 weeks, Bharat reached a high of ₹35.88 (on January 7, 2025) and a low of ₹19.00 (on February 17, 2025).
- What is the market cap and P/E ratio for BIBCL?
- Curious about Bharat's size and valuation? Its market capitalization stands at 910.67M. When it comes to valuation, the P/E ratio (trailing twelve months) is -5.48, and the forward P/E (looking ahead) is N/A.
- Does BIBCL pay dividends? If so, what's the yield?
- As for dividends, Bharat isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Bharat's main competitors or similar companies to consider before investing?
When looking at Bharat, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Biocon
BIOCON470.24B Healthcare Biotechnology 0.46% 33.08% OneSource Specialty
ONESOURCE214.44B Healthcare Biotechnology 9.48% 9.48% Zota Health Care
ZOTA46.71B Healthcare Biotechnology 149.64% 455.76% Dishman Carbogen
DCAL45.33B Healthcare Biotechnology 57.44% 186.03% Panacea Biotec
PANACEABIO26.29B Healthcare Biotechnology 38.79% 196.98% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Bharat Immunologicals & Biologicals Corporation Limited? (e.g., ROE, Debt/Equity)
- To get a sense of Bharat's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -21.00%, the Debt to Equity ratio from the most recent quarter is 94.48, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for BIBCL?
- Looking at Bharat's growth, its revenue over the trailing twelve months (TTM) was INR77M. Compared to the same quarter last year (YoY), quarterly revenue grew by -99.40%, and quarterly earnings saw a YoY growth of -100.00%.
- How much of BIBCL stock is held by insiders and institutions?
- Wondering who owns Bharat stock? Company insiders (like executives and directors) hold about 59.25% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.